Related Experiment Video

Updated: Jun 3, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis

Nicole A Neuman1, Elizabeth Petri Henske

  • 1Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

EMBO Molecular Medicine
|March 18, 2011
PubMed

Insights

Tuberous Sclerosis Complex (TSC) proteins TSC1 and TSC2, along with Rheb, have functions beyond the known mTOR pathway. This research explores these non-canonical roles and their potential therapeutic applications for TSC and LAM patients.

Area of Science:

  • Genetics and Molecular Biology
  • Cell Signaling
  • Disease Mechanisms

Background:

  • Tuberous Sclerosis Complex (TSC) genes TSC1 and TSC2 form a complex that inhibits the small G-protein Rheb.
  • Most research focuses on Rheb's downstream target, the mammalian Target of Rapamycin (mTOR).
  • The TSC-Rheb pathway is implicated in various cellular processes and diseases.

Purpose of the Study:

  • To investigate clinically relevant functions and targets of TSC1, TSC2, and Rheb independent of mTOR.
  • To present evidence for non-canonical functions within the TSC-Rheb signaling network.
  • To discuss the potential clinical and therapeutic implications of these non-canonical functions.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of genetic and molecular data related to TSC1, TSC2, and Rheb.
  • Proposal of a standard of evidence for non-canonical pathway functions.

Main Results:

  • Evidence suggests that TSC1, TSC2, and Rheb possess functions independent of the mTOR pathway.
  • These non-canonical functions represent a significant area for further research.
  • The identified non-canonical roles have potential clinical relevance.

Conclusions:

  • The TSC-Rheb signaling network has clinically relevant functions that are independent of mTOR.
  • Establishing a standard of evidence is crucial for validating these non-canonical functions.
  • Further research into these pathways could lead to novel therapeutic strategies for TSC and LAM.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...